comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 23:03:47 - browse：952

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Pharma budget tightening trickles down to Doximity

WSS

CDC overhauls leadership of center that led response to Covid

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Who are the detained American citizens released from prison in Iran?

Target recalls 2.2 million additional candles due to laceration, burn hazards

Some of the ways extreme heat will change life as we know it

Colonoscopy prep: Liquid

hotspot

comprehensive

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Neuroscience’s long legacy of racism

Psychedelics group wrestles with new pharma identity

Gene editing the human germline: What are the risks?

How one medical school became remarkably diverse

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

How one medical school became remarkably diverse

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Plastic surgeons increase patient psychiatric screenings

leisure time

Orchard's therapy for neuron disease in children wins FDA approval

Maui funeral service workers on devastation of fires: 'I'm in shock'

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

CDC overhauls leadership of center that led response to Covid

CVS Caremark has created a new ploy: the drug ‘rebate credit’

An innovative path out of biotech’s “valley of death”

Wikipedia

explore

hotspot

Wikipedia